RIBI IMMUNOCHEM RESEARCH, INC. – Trademark Portfolio

Entity Type: 03

RIBI IMMUNOCHEM RESEARCH, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. The owner is based in HAMILTON, MT.

N.E. 581 OLD CORVALLIS RD.

P. O. BOX 1409

HAMILTON, MT 59840

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

RIBI IMMUNOCHEM RESEARCH, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

31
Natural Agricultural Products (3 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does RIBI IMMUNOCHEM RESEARCH, INC. have?

RIBI IMMUNOCHEM RESEARCH, INC. has 8 U.S. trademarks filed with the USPTO.

What trademark classes does RIBI IMMUNOCHEM RESEARCH, INC. file in?

RIBI IMMUNOCHEM RESEARCH, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 31 (Natural Agricultural Products), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is RIBI IMMUNOCHEM RESEARCH, INC.'s trademark registration success rate?

RIBI IMMUNOCHEM RESEARCH, INC. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.